early thursday, Eli Lilly (LLY) reported adjusted earnings of $2.09 per share on fourth-quarter sales of $7.3 billion. LLY shares fell accordingly.
Analysts surveyed by FactSet expect Lilly to earn $1.78 per share on sales of $7.33 billion.
In the year-ago quarter, Lilly earned $2.17 per share on sales of approximately $8 billion.
For the year, the pharmaceutical company led adjusted earnings per share of $8.35 to $8.55 and sales of $30.3 billion to $30.8 billion. LLY’s equity analysts forecast earnings per share of $8.35 and revenue of $30.47 billion.
Before today’s stock market open, LLY shares fell 2.3% near 334.60. According to MarketSmith.com, the stock recently fell below its flat base low at 375.35 buy points.
More to come.
Follow Allison Gatlin on Twitter. @IBD_AGatlin.
You may also like:
Thermo Fisher shows bullish outlook as Boston Scientific turns a profit on inline reports
AbbVie’s 20-year Humira exclusivity ends with Amgen’s 55% discount knockoffs
Looking for the next big stock market winner? Get started with these 3 steps
Get timely buy/sell alerts on the IBD leaderboard
Explore IBD investment strategies and gain actionable market insights